Cargando…

The long non-coding RNA Linc-GALH promotes hepatocellular carcinoma metastasis via epigenetically regulating Gankyrin

Hepatocellular carcinoma (HCC) is the most prevalent subtype of liver cancer, and it is characterized by high rate of metastasis and recurrence. Recent studies have boosted our understanding that Gankyrin contributes to both of these pathological properties, but the mechanisms underlying its aberran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xiaoliang, Lou, Yun, Tang, Junwei, Teng, Yue, Zhang, Zechuan, Yin, Yin, Zhuo, Han, Tan, Zhongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349924/ https://www.ncbi.nlm.nih.gov/pubmed/30692513 http://dx.doi.org/10.1038/s41419-019-1348-0

Ejemplares similares

Gankyrin gene deletion followed by proteomic analysis: insight into the roles of Gankyrin in Tumorigenesis and Metastasis
por: Luo, Xue, et al.
Publicado: (2012)

LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/stat3/akt pathway
por: Song, Xuan, et al.
Publicado: (2013)

Bidirectional transcription of Linc00441 and RB1 via H3K27 modification-dependent way promotes hepatocellular carcinoma
por: Tang, Junwei, et al.
Publicado: (2017)

Gankyrin activates the hedgehog signalling to drive metastasis in osteosarcoma
por: Wang, Chongchong, et al.
Publicado: (2021)

Discovery of a small-molecule binder of the oncoprotein gankyrin that modulates gankyrin activity in the cell
por: Chattopadhyay, Anasuya, et al.
Publicado: (2016)

Linc-KILH potentiates Notch1 signaling through inhibiting KRT19 phosphorylation and promotes the malignancy of hepatocellular carcinoma
por: Zhang, Xudong, et al.
Publicado: (2021)

Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma
por: Yang, Chun, et al.
Publicado: (2016)

Long non-coding RNA Myd88 promotes growth and metastasis in hepatocellular carcinoma via regulating Myd88 expression through H3K27 modification
por: Xu, Xiaoliang, et al.
Publicado: (2017)

Gankyrin and TIGAR cooperatively accelerate glucose metabolism toward the PPP and TCA cycle in hepatocellular carcinoma
por: Yang, Chun, et al.
Publicado: (2022)

Gankyrin Is Frequently Overexpressed in Cervical High Grade Disease and Is Associated with Cervical Carcinogenesis and Metastasis
por: Liu, Yuan, et al.
Publicado: (2014)

Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma
por: Sakurai, Toshiharu, et al.
Publicado: (2017)

Gankyrin as Potential Biomarker for Colorectal Cancer With Occult Liver Metastases
por: Wang, Chengxing, et al.
Publicado: (2021)

KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling
por: Han, Jihua, et al.
Publicado: (2018)

Resurfaced Shape Complementary Proteins That Selectively Bind the Oncoprotein Gankyrin
por: Chapman, Alex M., et al.
Publicado: (2014)

Long Non-coding RNA LINC00628 Interacts Epigenetically with the LAMA3 Promoter and Contributes to Lung Adenocarcinoma
por: Xu, Shu-Feng, et al.
Publicado: (2019)

Effects of Ligand Binding on the Mechanical Properties of Ankyrin Repeat Protein Gankyrin
por: Settanni, Giovanni, et al.
Publicado: (2013)

Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma
por: Hwang, Ju-Ae, et al.
Publicado: (2014)

Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation
por: D’Souza, Amber M., et al.
Publicado: (2018)

RP11-40C6.2 Inactivates Hippo Signaling by Attenuating YAP1 Ubiquitylation in Hepatitis B Virus-associated Hepatocellular Carcinoma
por: Zhuo, Han, et al.
Publicado: (2023)

Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance
por: Jing, Hongbiao, et al.
Publicado: (2014)

Characterization of the Binding Interaction between the Oncoprotein Gankyrin and a Grafted S6 ATPase
por: Chapman, Alex M., et al.
Publicado: (2014)

Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver Cancer
por: D’Souza, Amber M., et al.
Publicado: (2022)

A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma
por: Tang, J, et al.
Publicado: (2014)

Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis
por: Zhao, Xiaotong, et al.
Publicado: (2016)

Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma
por: Wang, Chao, et al.
Publicado: (2018)

The oncoprotein gankyrin promotes the development of colitis-associated cancer through activation of STAT3
por: Sakurai, Toshiharu, et al.
Publicado: (2017)

LMX1B-associated gankyrin expression predicts poor prognosis in glioma patients
por: Guo, Xu, et al.
Publicado: (2020)

The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells
por: Camacho-Moll, Maria E., et al.
Publicado: (2019)

LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription
por: Xiu, Bingqiu, et al.
Publicado: (2019)

Decreased long non‐coding RNA lincFOXF1 indicates poor progression and promotes cell migration and metastasis in osteosarcoma
por: Yang, Shengquan, et al.
Publicado: (2020)

Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα
por: Sun, Ying, et al.
Publicado: (2018)

Long non-coding RNA AB209630 suppresses cell proliferation and metastasis in human hepatocellular carcinoma
por: Li, Teng, et al.
Publicado: (2017)

Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma
por: Tang, Junwei, et al.
Publicado: (2015)

Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway
por: Wang, Wu-ping, et al.
Publicado: (2016)

Deficiency of Gankyrin in the small intestine is associated with augmented colitis accompanied by altered bacterial composition of intestinal microbiota
por: Sakurai, Toshiharu, et al.
Publicado: (2020)

Role of a 19S Proteasome Subunit- PSMD10(Gankyrin) in Neurogenesis of Human Neural Progenitor Cells
por: Sahu, Indrajit, et al.
Publicado: (2019)

Helicobacter pylori and Epstein-Barr Virus Coinfection Stimulates Aggressiveness in Gastric Cancer through the Regulation of Gankyrin
por: Kashyap, Dharmendra, et al.
Publicado: (2021)

Identification of a covalent binder to the oncoprotein gankyrin using a NIR-Based OBOC screening method
por: Maresh, Marianne E., et al.
Publicado: (2021)

Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway
por: Zhao, X, et al.
Publicado: (2015)

Gankyrin Drives Malignant Transformation of Gastric Cancer and Alleviates Oxidative Stress via mTORC1 Activation
por: Huang, Bo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ueq1seuq30rbdjrrp1ds9r5lrp